Midway through 2026, OHE reflects on the year’s defining health economics shifts, from US MFN pricing to NICE, EU JCA and ...
A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...
World Health Assembly (WHA) 2026 side events by OHE in Geneva on cardiovascular disease, climate policy and immunisation, ...
US drug pricing policy and Congressional Budget Office (CBO) model of the Build Back Better Act examining pharmaceutical R&D ...
In this episode of A Dose of Economics, Grace Hampson sits down with OHE’s Amanda Cole and global market access consultant Neil Grubert to discuss the biggest developments in U.S drug pricing policy – ...
A Dose of Economics is OHE’s podcast on health economics, healthcare policy, HTA, AI, drug pricing, and resource allocation ...
A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...
ASCVD drives major global health and economic burden, with LDL-C responsible for up to one-third. Better prevention and management could reduce costs and save lives.
A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...
The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s ...
A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results